Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Operational Update June 4, 2025 Next Post Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute June 4, 2025 Related Posts Trump, Rio Tinto Push for Copper as Court Halts Arizona Mine Transfer August 22, 2025 NATO Defense Spending Pledge Puts Spotlight on Platinum Group Metals August 22, 2025 West High YieldResources Ltd. Announces Exercise of Options and Warrants August 22, 2025
